Serbia's domestic PPI rises 0.8% y/y in Nov
Bulgaria's Etropal swings to 9-mo cons net profit
Arco Vara appoints general manager for Bulgaria
N. Macedonia's Halk Osiguruvanje completes 3 mln euro cap hike
Romania to get 34 mln euro in EU funds for drought recovery
Sep 04, 2023 16:06 EEST
September 4 (SeeNews) - Bulgarian pharmaceuticals producer Sopharma [BUL:SFA] has acquired new shares in real estate investment trust Sopharma Properties [BUL:SFI], lifting its stake to 45.59% from 40.03%, the target company said on Monday.
Sopharma now owns a little over 10 million voting shares in the REIT, Sopharma Properties said in a bourse filing.
You can subscribe to our M&A newsletter here
The buyer acquired 986,243 shares in the property trust on Friday, at prices ranging between 9.60 levs ($5.30/4.90 euro) and 9.75 levs, a separate company filing showed.
Shares in Sopharma Properties closed at 9.60 levs in its most recent trading session on Friday, for a market capitalisation of The company has seen the value of its stock increase by over 7% in the past 12 months, bourse data show.
In June, Sopharma Properties' shareholders approved the distribution of a gross dividend of 0.165 levs per share for 2022, or some 3.62 million levs out of last year's net profit of 10.27 million levs.
(1 euro = 1.95583 levs)
You have run out of free articles this month.
Sign up in for
and get ten (10) free articles per month or sign up for
and get unlimited access.
Browse our free newsletter options